Profitable companies and non-Profitable Biotech companies (rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and Market Cap match the large global pharma. Dividend and consolidation could be the future drivers and continue to attract long term investors. Optimism prevails around the future of this sector as a whole which was reflected in the unprecedented rally in shares in 2012.
This trend continued in the next five years driven by launch of Innovative drugs catering to unmet needs in Alzheimer’s, HCV, osteoporosis, RA, Psoriasis, MS, Dyslipidemia, Cystic fibrosis, Cancer and orphan diseases. Drug approvals and label expansion of existing portfolio of launched drugs and data from late stage pipeline drugs should maintain the growth momentum and investors interest.
The early part of the previous decade (2010-20) was spent recovering from the big acquisitions made by this sector but followed by the exercising of some restrain for similar large acquisitions as investors wanted to see the returns reflected in the top-line and EPS. However in- licensing of early or mid stage compounds or small acquisitions continued since the Rising Stars kept throwing the bait by taking risks and innovate using novel technology platforms or validating novel targets for treating diseases.
Patent expiry impact was also modest as majority had “not so easy to copy” biologics and other drugs in their portfolio. They, however were not complacent and were not leaving any stones unturned to meet the challenges as well as exploring emerging market opportunities with local partners. Favorable regulatory environment finally saw biosimilar mAbs entry in regulated markets The optimism of biosimilar players is reflected in the maturing pipeline. Para IV Filing from other generic players continues to pour leaving room for surprises and volatility.
Moving forward the sector should see a strategic rise of the digital mindset and further adoption of transformative and augumentative technologies. While mergers & acquisitions can still expect a sharper focus despite being more traditional, external innovation should result in a meaningful shift in culture through innovative and creative partnerships with both new entrants and less traditional companies.
There will be an increasing demand for even more transparency and disclosure and a need for real relationship-driven partnerships will encroach across all sector stakeholders including regulators, patients, advocacy groups and also to outsourcing players critical to the supply chain. Data will be a dominating force behind new revenue models and crucial to understanding and delivering an exceptional patient experience. Pricing will continue to exert much pressure, increasing access to drugs, growth of gene and cell therapies, and uncertain trade policies will further change the dynamics of the market.
Industry News
- Semipermeable species boundaries allow gene flow but block hybrid swarm in desert fishby Bioengineer on July 15, 2026 at 4:25 am
Hybridization is often described as a force that can blur species boundaries and redirect evolution, yet its consequences for endangered taxa—especially in human-altered landscapes—are still poorly understood. A new study from the San Juan River now suggests that gene flow can occur freely between native catostomids without necessarily producing a self-sustaining “hybrid swarm” that would
- Imaging Study Finds Widespread Brain Connectivity Loss in Schizophreniaby Bioengineer on July 15, 2026 at 4:22 am
A new study led by researchers at Rutgers University and Yale University uses specialized positron emission tomography (PET) to measure synaptic connections directly in the living human brain, offering fresh clues to the biological basis of schizophrenia. Published in Molecular Psychiatry, the work moves beyond conventional imaging by targeting the density of synapses—small contact points
- Emerging Tick-Borne Virus Sparks Growing Concernby Bioengineer on July 15, 2026 at 4:10 am
RIVERSIDE, Calif. — A new study from the University of California, Riverside reveals how orthonairoviruses, a group of tick-borne pathogens, can disarm key immune defenses. The work points to molecular strategies that may help these viruses establish infection and highlights why they remain a concern for emerging infectious disease risk. Orthonairoviruses include Crimean-Congo hemorrhagic fever
- New insights may improve the quality of 3D-printed aluminum componentsby Bioengineer on July 15, 2026 at 3:54 am
Scientists at The University of Manchester report that even modest temperature variations during molten metal deposition (MMD) can reshape the internal microstructure of aluminium components and strongly influence defect formation. Their results point to practical, physics-based levers for improving part quality in a metal 3D-printing approach designed for more controlled thermal conditions than many conventional
- Ulinastatin Shows Therapeutic Effects in Liver Diseasesby Bioengineer on July 15, 2026 at 3:53 am
Sepsis, major surgery, drug exposure, viruses, and long-term illnesses all converge on the liver—an organ central to nutrient metabolism, detoxification, bile production, and immune signaling. Its dense vascular and cellular architecture also makes it especially susceptible to inflammatory and oxidative injuries that can quickly escalate into organ dysfunction. In a new review in Hepatobiliary Communications,
- Emergency High-Risk Surgery Costs Older Adults a Month of Home Timeby Bioengineer on July 15, 2026 at 3:46 am
Older adults who undergo high-risk emergency abdominal surgery may spend far less time living independently at home in the year after their operation than peers who receive lower-risk procedures, according to a new study in the Journal of the American College of Surgeons (JACS). Rather than focusing only on survival, researchers used a patient-centered metric
- Osteocyte Parvalbumin Drives Mechanotransduction to Reduce Osteoarthritis Progressionby Bioengineer on July 15, 2026 at 3:34 am
A new study published in Nature Communications (2026) spotlights an unexpected molecular player in the battle against osteoarthritis: osteocyte parvalbumin. Osteocytes, the bone’s embedded mechanosensors, constantly translate mechanical forces—such as walking-induced strain—into biochemical signals. When that signaling goes awry, cartilage degradation and joint inflammation can accelerate. The researchers report that parvalbumin acts as a mechanotransduction
- Slow-Speed Protocol Tests Remote Exercise in Three Randomized Trials to Prevent Parkinson’sby Bioengineer on July 15, 2026 at 3:23 am
A new set of clinical trials is aiming to answer a deceptively simple question: can exercise delivered at a distance slow the biological march toward Parkinson’s disease? In a study protocol published in npj Parkinson’s Disease, investigators outline “Slow-SPEED,” a program built around remotely supervised activity designed to be practical for people at risk long
- Screening for Benign Positional Vertigo in Older Patients at Falls Clinicsby Bioengineer on July 15, 2026 at 3:10 am
A new study highlights a largely preventable cause of dizziness in older adults—benign paroxysmal positional vertigo (BPPV)—and argues that falls clinics should routinely screen for it. Researchers focusing on seniors who present after falls or fall risk events report that BPPV can be both common and clinically actionable, meaning targeted treatment could reduce repeated episodes
- Mussel Protein Forms Protective Vessel Barrier, Then Disappears in Pancreatic Tumorsby Bioengineer on July 15, 2026 at 2:53 am
Pancreatic cancer remains among the deadliest malignancies, largely because it is detected late and is shielded by a dense tissue environment that makes efficient drug delivery difficult. Even when chemotherapy is administered intravenously, many drugs fail to reach tumors at therapeutic levels. A new study from POSTECH proposes a strategy to solve both problems at
- KAUST Researchers Create Wearable Tech to Monitor Medicines in Real Timeby Bioengineer on July 15, 2026 at 2:49 am
Wearable health technology is getting a new job: measuring how medicines behave inside the body. Researchers at King Abdullah University of Science and Technology (KAUST) have built a microneedle patch designed to continuously track drug concentrations beneath the skin and stream the results to a smartphone in real time. The work highlights a shift from
- Study Maps Photogenerated Hole Evolution During Separation and Transfer in Photocatalysisby Bioengineer on July 15, 2026 at 2:45 am
A team has mapped, in real time and with nanoscale precision, how photogenerated holes travel and react inside a facet-engineered bismuth vanadate photocatalyst. Using a home-built in-situ transient reflection microscope (TRM), the researchers visualized the full spatiotemporal pathway of these charge carriers at the solid–liquid interface—where photocatalysis often succeeds or fails. The study tackles a
- Insilico Medicine, Bora Pharmaceuticals partner on AI drug discovery and developmentby Bioengineer on July 15, 2026 at 2:40 am
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufacturing leader. The collaboration, disclosed on July 15, 2026, is structured around definitive agreements that will define scope, governance, and execution. Insilico’s focus is to pair its AI-driven discovery capabilities with Bora’s operational depth
- New Cell Imaging Technique Illuminates Previously Hidden Cellular Blind Spotsby Bioengineer on July 15, 2026 at 2:31 am
Cells behave like crowded cities, yet many crucial molecular conversations have been impossible to watch directly in real time. Traditional microscopy often averages enzyme activity across a whole cell, hiding where reactions actually occur—down to tiny nanodomains where signaling is decided. A team at the University of Illinois Chicago has now introduced an imaging strategy
- Creatine supplements may boost tumor metastasis through megakaryocyte signaling pathwaysby Bioengineer on July 15, 2026 at 2:10 am
In a finding that challenges a popular sports supplement’s reputation, researchers report that exogenous creatine can accelerate tumor metastasis through an unexpected signaling route. The work, published in Nature Communications (2026), links creatine supplementation to changes in how megakaryocytes—blood-cell precursors best known for clotting—communicate with cancer cells. The study focuses on a pathway centered on
- fMRI reveals target-specific brain networks during active GPi deep brain stimulationby Bioengineer on July 15, 2026 at 1:58 am
A new study reports that functional MRI can reveal how deep brain stimulation (DBS) in the globus pallidus internus (GPi) engages distinct, target-dependent brain circuits. The work, led by Santyr and colleagues, uses active GPi DBS while participants undergo fMRI, offering a systems-level view of stimulation effects that goes beyond electrode placement and clinical symptom
- Drones and Ensemble AI Uncover Hidden Patterns in Urban Water Pollutionby Bioengineer on July 15, 2026 at 1:48 am
Urban rivers are vital for biodiversity, local climate regulation, and everyday water supply, yet many are increasingly pressured by eutrophication. This nutrient-driven process can accelerate algal blooms, reduce dissolved oxygen, and degrade water quality. Traditional monitoring relies on labor-intensive sampling and laboratory analysis, which often produces sparse data and misses rapid spatial changes along entire
- Discovery Paves Way for Drug Therapies for Hypopigmentation Conditionsby Bioengineer on July 15, 2026 at 1:41 am
Ampyrone—an NSAID-related compound—has emerged as a promising way to enhance melanin production in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators. The work points toward an ampyrone-derived therapy for hypopigmentation disorders, where melanin levels are abnormally low or absent. Hypopigmentation can occur in severe genetic forms
- Gene Therapy Reverses Fragile X Traits in Preclinical Studyby Bioengineer on July 15, 2026 at 1:40 am
A gene therapy aimed at correcting fragile X syndrome by restoring the missing FMR1 protein has demonstrated multiple disease-relevant improvements in a mouse model, according to a new study in Gene Therapy. Fragile X syndrome, the most common inherited form of intellectual disability and a major single-gene contributor linked to autism, currently has no cure;
- Evolution of Hidden Core Machinery Beneath the Surfaceby Bioengineer on July 15, 2026 at 1:25 am
A new evolutionary study is upending a century-old assumption about how vertebrate muscles work. For decades, researchers have treated muscle contraction as a largely conserved machine across animals: myosin pulls on actin to generate force, and the basic biochemical partnership was presumed to be nearly identical in birds, reptiles, amphibians, and fish. But by mining
- Protecting Your Drug Patent in Global Markets: Strategies and Challengesby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 27, 2025 at 9:19 am
Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source
- Drafting Drug Patent Applications for Biologic Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 26, 2025 at 11:45 am
The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source
- Successfully Patenting Drug Combinations: Strategies and Challengesby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 26, 2025 at 9:57 am
Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source
- Effective Strategies for Generic Drug Price Settingby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 25, 2025 at 9:17 am
The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source
- Optimizing the Generic Drug Supply Chain: Strategies for Successby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 24, 2025 at 11:56 pm
Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source
- FDA Updates: What Do the Latest Changes Mean for Generic Drug Approval?by Insights: DrugPatentWatch - Find Your Next Blockbuster on February 24, 2025 at 8:55 pm
Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source
- Regulatory Challenges in the Latin American Generic Drug Marketby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 24, 2025 at 4:10 pm
Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source
- Analyzing the cost-effectiveness of biosimilars in different healthcare systemsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 23, 2025 at 11:27 am
The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source
- How to Achieve High-Quality Standards in Generic Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 20, 2025 at 11:21 am
Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source
- The Role of Quality Assurance in Generic Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 19, 2025 at 11:07 am
The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source
- DrugChatter: Can lurbinectedin treat ovarian cancer?by DrugChatter on February 19, 2025 at 6:44 am
Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source
- Regulatory considerations for biosimilar clinical efficacy trialsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 18, 2025 at 3:27 pm
Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source
- The basics of drug patent searchingby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 18, 2025 at 10:38 am
Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source
- Navigating the Generic Drug Approval Process: A Comprehensive Guideby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 17, 2025 at 10:33 am
Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source
- Strategies for successful biosimilar-to-biosimilar switchingby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 16, 2025 at 4:04 pm
The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source
- Study Reveals Key Predictors of Early Patent Challenges for FDA-Approved Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 14, 2025 at 11:40 am
The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source
- The Role of Partnerships in Generic Drug Developmentby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 13, 2025 at 9:12 am
Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source
- DrugChatter: Does fish oil interact with vascepa?by DrugChatter on February 12, 2025 at 9:10 pm
Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source
- How to Manage Generic Drug Development Timelines: Strategies for Successby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 12, 2025 at 9:10 am
The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source
- DrugChatter: How does lipitor affect white wine?by DrugChatter on February 11, 2025 at 4:56 pm
The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source
- Announcing DIYbiosphere: an open source project to connect DIYbio related activities worldwideby Jason Bobe on March 17, 2018 at 10:53 am
With significant growth in activities globally, our /local page has strained to keep up and simply is not a great...

